Page last updated: 2024-11-06

schizandrol b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

schizandrol B: from Schizandra chinensis, plant used as tonic in traditional Chinese medicine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68781
CHEMBL ID1834755
CHEBI ID31272
SCHEMBL ID2701466
MeSH IDM0104134

Synonyms (18)

Synonym
schisandrol b
schizandrol b
wuweizi alcohol b
NCGC00181777-01
besigomsin (jan/inn)
D01752
NCGC00183134-01
CHEMBL1834755
tox21_113433
tox21_113370
dtxcid0028876
dtxsid7048950 ,
cas-58546-54-6
SCHEMBL2701466
schisandrol-b
ZWRRJEICIPUPHZ-SFDCACGMSA-N
CHEBI:31272
PD014436

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" In this work, plasma pharmacokinetic characteristics of lignans components after oral administration SMS were investigated using UPLC-Q-TOF/MS method."( Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS.
Han, Y; Sun, H; Wang, X; Wei, W; Wu, F; Zhang, A, 2013
)
0.39
" This paper was designed to study on the plasma pharmacokinetic for its absorption process, and to compare the pharmacokinetics of its active ingredients in normal and insomnic rats orally administrated with the prescription."( Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
Bi, K; Chen, X; Fan, R; Geng, L; He, B; Jia, Y; Li, Q; Su, D; Wei, B; Zhao, L, 2013
)
0.39
" After oral administration of FZHY at a dose of 15g/kg, the pharmacokinetic behaviors of schizandrin A (SIA), schizandrin B (SIB), schizandrin C (SIC), schisandrol A (SOA), Schisandrol B (SOB) and schisantherin A (STA) have been significantly changed in hepatic fibrosis rats compared with the normal rats, and their AUC(0-t) values were increased by 235."( Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Liu, CH; Liu, S; Tao, YY; Yang, T; Zheng, TH, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" As the oral bioavailability of paclitaxel was increased about 3-fold in the presence of Sch B, the concomitant use of Sch B may provide a benefit in the oral delivery of paclitaxel."( Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats.
Bi, H; Hu, J; Huang, M; Huang, Z; Jin, J; Zhao, L; Zhong, G, 2010
)
0.36
" These results suggested that GA attenuated the increase in BP via preservation of vascular NO bioavailability not only by inhibiting ROS production but also by preventing the impairment of eNOS function in the vasculature of Ang II-induced hypertensive mice."( Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability.
Jin Lee, S; Kim, CD; Ung Bae, J; Whan Choi, Y; Whan Hong, K; Won Seo, K; Wook Yun, J; Youn Park, S; Young Park, J, 2012
)
0.38
" Collectively, an increase in BP in mice treated with Ang II was markedly attenuated by GJ, which was attributed to the preservations of vascular NO bioavailability and eNOS function, and to the inhibition of ROS production in Ang II-induced hypertensive mice."( Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.
Choi, YW; Kim, CD; Lee, SJ; Park, SY; Ye, BH, 2015
)
0.42
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Six lignans pretreatment before APAP dosing could prevent the depletions of total liver glutathione (GSH) and mitochondrial GSH caused by APAP."( Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation.
Bi, H; Chen, P; Fan, X; Huang, M; Jiang, Y; Tan, H; Wang, Y; Zeng, H, 2015
)
0.42
" Kampo formulation containing SF is usually prepared as decoctions in the dosage form of whole crude drug (W), as its size is small enough to measure using a spoon."( Effects of crushed Schisandra Fruit on the content of lignans in Kampo decoction.
Atsumi, T; Makino, T; Ohtsuka, I; Yokogawa, T; Yokoyama, Y, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tanninAny of a group of astringent polyphenolic vegetable principles or compounds, chiefly complex glucosides of catechol and pyrogallol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency33.49830.000811.382244.6684AID686978
estrogen nuclear receptor alphaHomo sapiens (human)Potency26.80620.000229.305416,493.5996AID743075
aryl hydrocarbon receptorHomo sapiens (human)Potency18.41110.000723.06741,258.9301AID743085; AID743122
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID622787Induction of apoptosis in human HCT116 cells assessed as accumulation of cleaved caspase-7 at 10 uM after 48 hrs by Western blot analysis2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
AID622843Induction of apoptosis in human HCT116 cells assessed as shrunken nuclei at 10 uM after 48 hrs by fluorescence microscopy method2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
AID622844Induction of apoptosis in human HCT116 cells assessed as fragmented nuclei at 10 uM after 48 hrs by fluorescence microscopy method2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
AID622786Anticlonogenic activity against human HCT116 cells at 2 uM after 7 days using crystal violet staining2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
AID622845Induction of apoptosis in human HCT116 cells assessed as condensed chromatin at 10 uM after 48 hrs by fluorescence microscopy method2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
AID622841Antiproliferative activity against human HCT116 cells assessed as cell growth inhibition at 10 to 40 uM by WST-8 assay2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
AID622842Antiproliferative activity against human HCT116 cells assessed as cell growth inhibition after 12 to 48 hrs by WST-8 assay2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
AID622785Induction of apoptosis in human HCT116 cells assessed as increase in cleaved PARP level at 10 uM by Western blot analysis2011Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20
A compound isolated from Schisandra chinensis induces apoptosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (113)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (16.81)18.7374
1990's18 (15.93)18.2507
2000's12 (10.62)29.6817
2010's50 (44.25)24.3611
2020's14 (12.39)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.20 (24.57)
Research Supply Index4.76 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other116 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]